These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 35075370)
21. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
22. Identification of Potential Genetic Biomarkers and Target Genes of Peri-Implantitis Using Bioinformatics Tools. Zhang X; Wang Z; Hu L; Shen X; Liu C Biomed Res Int; 2021; 2021():1759214. PubMed ID: 34931168 [TBL] [Abstract][Full Text] [Related]
23. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma. Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410 [TBL] [Abstract][Full Text] [Related]
24. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
25. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis. Xu Y; Kong D; Li Z; Qian L; Li J; Zou C PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255 [TBL] [Abstract][Full Text] [Related]
26. Integrative analyses of key genes and regulatory elements in fluoride-affected osteosarcoma. Li M; Jin X; Guo F; Wu G; Wu L; Deng S J Cell Biochem; 2019 Sep; 120(9):15397-15409. PubMed ID: 31037778 [TBL] [Abstract][Full Text] [Related]
27. Identification of potential crucial genes and key pathways in osteosarcoma. Liu J; Wu S; Xie X; Wang Z; Lei Q Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038 [TBL] [Abstract][Full Text] [Related]
28. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
29. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
30. Bioinformatics Analysis Identifies Hub Genes and Molecular Pathways Involved in Sepsis-Induced Myopathy. Ning YL; Yang ZQ; Xian SX; Lin JZ; Lin XF; Chen WT Med Sci Monit; 2020 Feb; 26():e919665. PubMed ID: 32008037 [TBL] [Abstract][Full Text] [Related]
31. Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis. Xie B; Li Y; Zhao R; Xu Y; Wu Y; Wang J; Xia D; Han W; Chen D Biomed Res Int; 2018; 2018():4761064. PubMed ID: 29850522 [TBL] [Abstract][Full Text] [Related]
32. Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma. Guan D; Tian H World J Surg Oncol; 2017 Sep; 15(1):177. PubMed ID: 28934958 [TBL] [Abstract][Full Text] [Related]
33. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
34. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing. Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494 [TBL] [Abstract][Full Text] [Related]
35. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms. Guo T; Hou D; Yu D Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495 [TBL] [Abstract][Full Text] [Related]
36. A comprehensive analysis of candidate genes and pathways in pancreatic cancer. Liu J; Li J; Li H; Li A; Liu B; Han L Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614 [TBL] [Abstract][Full Text] [Related]
37. Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386 [TBL] [Abstract][Full Text] [Related]
38. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
39. Identification of key genes in osteosarcoma - before and after CDK7 treatment. An Y; Wang Y; Xu G; Liao Y; Huang G; Jin X; Xie C; Li Q; Yin D Medicine (Baltimore); 2021 Oct; 100(39):e27304. PubMed ID: 34596127 [TBL] [Abstract][Full Text] [Related]
40. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis. Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]